Caplacizumab (Cablivi®) accepted for use within NHS Scotland

Caplacizumab intravenous injection is approved for treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura, in conjunction with plasma exchange and immunosuppression.

Scottish Medicines Consortium